Plagiarism is checked by the leading plagiarism checker
Volume 4 Issue 2
March-April 2026
| Author(s) | Dr. P.S.R.MADHURI CH, Ms. ARSHIYA ANJUM SHEIK, Ms. POOJA SRI CHAMARTHI, Mr. SOUMEN MAL |
|---|---|
| Country | India |
| Abstract | Cancer remains a significant global health challenge, driving the need for enhanced treatment options. Chemotherapy, particularly for advanced stages, is a cornerstone of cancer management. Among the chemotherapeutic agents, platinum-based compounds have demonstrated considerable efficacy. Carboplatin, a second-generation platinum analog of cisplatin, was developed to offer a more favorable safety profile and is employed in the treatment of a variety of malignancies. Its mechanism of action involves the formation of platinum-DNA cross-links, which impede DNA replication and protein synthesis, ultimately leading to cancer cell death. While generally better tolerated than cisplatin, carboplatin can still elicit adverse effects, including myelosuppression and gastrointestinal disturbances. Renal function is a critical determinant of carboplatin dosage, as the kidneys are the primary route of drug elimination. The Area Under the Curve (AUC) method, employing the Calvert formula, is the standard for individualizing carboplatin doses, aiming to optimize therapeutic benefit while minimizing toxicity. Carboplatin is predominantly used for ovarian cancer but also shows efficacy in lung, head and neck, and bladder cancers. This review delves into chemotherapy strategies and platinum-based anticancer agents, with a specific focus on carboplatin's characteristics, mechanism of action, dosing principles, and clinical application. |
| Keywords | Area under the Curve, Cancer chemotherapy ,Carboplatin, Calvert formula, Glomerular filtration rate, Platinum-based anticancer agents, Pharmacokinetics, Renal function assessment |
| Discipline | Medical / Pharmacy |
| Published In | Volume 4, Issue 2, March-April 2026 |
| Published On | 2026-03-22 |
| DOI | https://doi.org/10.62127/aijmr.2026.v04i02.1234 |

E-ISSN 2584-0487All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.